For the quarter ending 2025-09-30, FBRX has $97,089K in assets. $93,414K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 93,414 | 106,144 | ||
| Prepaid expenses and other current assets | 1,998 | 1,472 | ||
| Total current assets | 95,412 | 107,616 | ||
| Property and equipment, at cost | 241 | - | ||
| Less accumulated depreciation | 93 | - | ||
| Property and equipment, net | 148 | 110 | ||
| Other assets | 1,529 | 57 | ||
| Total assets | 97,089 | 107,783 | ||
| Accounts payable | 5,491 | 5,301 | ||
| Accrued liabilities | 7,501 | 3,869 | ||
| Total current liabilities | 12,992 | 9,170 | ||
| Common stock, 0.001 par value 200,000,000 shares authorized as of september 30, 2025 (unaudited) and december 31, 2024 12,523,845 and 6,393,323 shares issued and outstanding as of september 30, 2025 (unaudited) and december 31, 2024, respectively | 13 | 12 | ||
| Additional paid-in capital | 282,675 | 279,504 | ||
| Accumulated other comprehensive (loss) income | -6 | - | ||
| Accumulated deficit | -198,585 | -180,903 | ||
| Total stockholders equity | 84,097 | 98,613 | ||
| Total liabilities and stockholders' equity | 97,089 | 107,783 | ||
Forte Biosciences, Inc. (FBRX)
Forte Biosciences, Inc. (FBRX)